BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32479759)

  • 1. Successful use of methylprednisolone for treating severe COVID-19.
    Liu J; Zheng X; Huang Y; Shan H; Huang J
    J Allergy Clin Immunol; 2020 Aug; 146(2):325-327. PubMed ID: 32479759
    [No Abstract]   [Full Text] [Related]  

  • 2. After 62 years of regulating immunity, dexamethasone meets COVID-19.
    Cain DW; Cidlowski JA
    Nat Rev Immunol; 2020 Oct; 20(10):587-588. PubMed ID: 32778829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan.
    Tu WJ; Cao J; Yu L; Hu X; Liu Q
    Intensive Care Med; 2020 Jun; 46(6):1117-1120. PubMed ID: 32253448
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
    Chrousos GP; Meduri GU
    Clin Immunol; 2020 Oct; 219():108550. PubMed ID: 32745524
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
    Lee WS; Margolskee E
    Blood; 2020 Aug; 136(7):914. PubMed ID: 32790856
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening.
    Tavazzi G; Civardi L; Caneva L; Mongodi S; Mojoli F
    Intensive Care Med; 2020 Jun; 46(6):1121-1123. PubMed ID: 32322918
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocilizumab treatment in COVID-19: A single center experience.
    Luo P; Liu Y; Qiu L; Liu X; Liu D; Li J
    J Med Virol; 2020 Jul; 92(7):814-818. PubMed ID: 32253759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19.
    Moutsopoulos HM
    Ann Rheum Dis; 2020 Sep; 79(9):1253-1254. PubMed ID: 32345616
    [No Abstract]   [Full Text] [Related]  

  • 11. Is COVID-19 more severe in older men?
    Liang X
    Postgrad Med J; 2020 Jul; 96(1137):426. PubMed ID: 32404490
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis.
    Mojtabavi H; Saghazadeh A; Rezaei N
    Eur Cytokine Netw; 2020 Jun; 31(2):44-49. PubMed ID: 32933891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotrienes, a potential target for Covid-19.
    Citron F; Perelli L; Deem AK; Genovese G; Viale A
    Prostaglandins Leukot Essent Fatty Acids; 2020 Oct; 161():102174. PubMed ID: 32977289
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection.
    Isidori AM; Pofi R; Hasenmajer V; Lenzi A; Pivonello R
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):472-473. PubMed ID: 32334645
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
    Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plea for the pathogenic role of immune complexes in severe Covid-19.
    Vuitton DA; Vuitton L; Seillès E; Galanaud P
    Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
    [No Abstract]   [Full Text] [Related]  

  • 18. Covid-19: Time for a paradigm change.
    Buonaguro FM; Ascierto PA; Morse GD; Buonaguro L; Puzanov I; Tornesello ML; Bréchot C; Gallo RC
    Rev Med Virol; 2020 Sep; 30(5):e2134. PubMed ID: 32618072
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.
    Liu XH; Lu SH; Chen J; Xia L; Yang ZG; Charles S; Yang Y; Lin Y; Lu HZ
    Emerg Microbes Infect; 2020 Dec; 9(1):1230-1232. PubMed ID: 32515651
    [No Abstract]   [Full Text] [Related]  

  • 20. A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019.
    Chen Q; Quan B; Li X; Gao G; Zheng W; Zhang J; Zhang Z; Liu C; Li L; Wang C; Zhang G; Li J; Dai Y; Yang J; Han W
    J Med Virol; 2020 Jun; 92(6):683-687. PubMed ID: 32162699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.